8CB0 Stock Overview
Engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Cannara Biotech Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.38 |
52 Week High | CA$0.73 |
52 Week Low | CA$0.36 |
Beta | 1.16 |
11 Month Change | -16.81% |
3 Month Change | -33.45% |
1 Year Change | -43.46% |
33 Year Change | -66.13% |
5 Year Change | -59.83% |
Change since IPO | -79.11% |
Recent News & Updates
Recent updates
Shareholder Returns
8CB0 | DE Personal Products | DE Market | |
---|---|---|---|
7D | -2.1% | 1.4% | 0.7% |
1Y | -43.5% | 2.0% | -0.08% |
Return vs Industry: 8CB0 underperformed the German Personal Products industry which returned 2% over the past year.
Return vs Market: 8CB0 underperformed the German Market which returned -0.5% over the past year.
Price Volatility
8CB0 volatility | |
---|---|
8CB0 Average Weekly Movement | 6.7% |
Personal Products Industry Average Movement | 4.1% |
Market Average Movement | 4.6% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8CB0's share price has been volatile over the past 3 months.
Volatility Over Time: 8CB0's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | n/a | Zohar Krivorot | cannara.ca |
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products. The company sells its products through wholesalers and online merchandisers.
Cannara Biotech Inc. Fundamentals Summary
8CB0 fundamental statistics | |
---|---|
Market cap | €34.77m |
Earnings (TTM) | €3.54m |
Revenue (TTM) | €51.24m |
10.8x
P/E Ratio0.7x
P/S RatioIs 8CB0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8CB0 income statement (TTM) | |
---|---|
Revenue | CA$76.95m |
Cost of Revenue | CA$47.81m |
Gross Profit | CA$29.13m |
Other Expenses | CA$23.82m |
Earnings | CA$5.32m |
Last Reported Earnings
May 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.059 |
Gross Margin | 37.86% |
Net Profit Margin | 6.91% |
Debt/Equity Ratio | 58.9% |
How did 8CB0 perform over the long term?
See historical performance and comparison